| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
April 18, 2017 |
|
|
| |
|
|
| |
|
|
|
Compliance4All, Online
2017-06-12
Overview:
Transition between Directive 2001/20/EC and Regulation EU No 536/2014
Until the Clinical Trials Regulation EU No will become applicable, all clinical
trials performed in the European Union are required to be conducted in
accordance with the Clinical Trials Directive 2001/20/EC.
Why should you Attend:
Because the current Directive will be significantly altered and replaced by a
Regulation which is legally binding on all Member States
Areas Covered in the Session:
The clinical trial database
The new evaluation procedure
Low intervention trials
Clinical trial assessment and results
Who Will Benefit:
Clinical Trial Managers
Regulatory Affairs
Medical Officers
Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
|
|
|
|
|
|
|
|
Organized by:
|
|
Compliance4All |
|
|
Invited Speakers:
|
|
Speaker Profile:
Salma Michor , PhD, MSc, MBA, CMgr, RAC is founder and CEO of Michor
Consulting Schweiz GmbH, serving such clients as Johnson & Johnson,
Novartis, Shire, Pfizer and Colgate Palmolive. Previously, Michor worked for
Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2017-06-11
|
|
|
|
|
|
|
|
Registration:
|
|
Full Details & Registration Link: http://www.compliance4all.com/control/w_product/~product_id=501313LIVE?channel=hum-molgen_Jun_2017_SEO
|
|
|
E-mail:
|
|
support@compliance4All.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|